Wedmont Private Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
HCM
FWCM
MSV
AIM
EB
SC
AP
IWA
MPWT
FFA
Wedmont Private Capital's ABBV Position: Q3 2026 in Review
Wedmont Private Capital increased its AbbVie (ABBV) stake by 13% in Q3 2026, buying an estimated $1.4M and bringing the position to 49,199 shares worth $13.4M. The position accounts for 0.32% of the portfolio, ranked #51.
Wedmont Private Capital first reported a position in ABBV in Q4 2021 and has held it in 20 quarters since. 246 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Wedmont Private Capital held 49,199 shares of AbbVie worth $13.4M as of Q3 2026.
- Wedmont Private Capital bought 5,468 AbbVie shares in Q3 2026, an estimated $1.4M.
- AbbVie made up 0.32% of Wedmont Private Capital's portfolio in Q3 2026, its #51 holding.
- Wedmont Private Capital first reported a position in AbbVie in Q4 2021 and has held it in 20 quarters since.
- 246 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Wedmont Private Capital's 13F filing for Q3 2026, filed 9 Oct 2026.